Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

BAOS Baosheng Media Group Holdings Ltd

1,90

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 13:00:00

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Baosheng Media (NASDAQ:BAOS)
Historical Stock Chart
Von Mär 2025 bis Apr 2025

Click Here for more Baosheng Media Charts.

Baosheng Media (NASDAQ:BAOS)
Historical Stock Chart
Von Apr 2024 bis Apr 2025

Click Here for more Baosheng Media Charts.

News Baosheng Media Group Holdings Ltd

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 7 März 2025 (1 Monat vor) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Montag 27 Januar 2025 (2 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 13 Januar 2025 (3 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mittwoch 9 Oktober 2024 (6 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Montag 30 September 2024 (6 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 27 September 2024 (6 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 12 Juni 2024 (10 Monate vor) • Edgar (US Regulatory)

Baosheng Media Group Holdings Limited Announces Filing of Current Report on Form 6-K with the SEC regarding Pending Legal Proceeding
Freitag 31 Mai 2024 (10 Monate vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 9 Mai 2024 (11 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mittwoch 8 Mai 2024 (11 Monate vor) • Edgar (US Regulatory)

Weitere Baosheng Media Group Holdings Ltd News-Artikel

Mcdonalds Corp 02 32 Mtn

Tialis Essential IT

Gladstone Commercial

Agios Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen